Evidence map›Paper›PMID 23515030›Full record

ArticleArchives of medical science : AMS2013

Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation.

Paweł Burchardt, Jakub Zurawski, Bartosz Zuchowski, Tomasz Kubacki, Dawid Murawa, Krzysztof Wiktorowicz, Henryk Wysocki

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Relation between lipoprotein-associated phospholipase ANeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Article
  9. Article
  10. Article
  11. Lipids, blood pressure and kidney update 2015.Lipids in health and disease · 2015
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Approach to reduction of blood atherogenicity.Oxidative medicine and cellular longevity · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paweł BurchardtDivision of Cardiology-Intensive Therapy, Department of Internal Medicine, Poznan University of Medical Sciences, Poland.
Jakub Zurawski
Bartosz Zuchowski
Tomasz Kubacki
Dawid Murawa
Krzysztof Wiktorowicz
Henryk Wysocki

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increased level of low-density lipoprotein (LDL) is a very well established risk factor of coronary artery disease (CAD). Unoxidized LDL is an inert transport vehicle of cholesterol and other lipids in the body and is thought to be atherogenic. Recently it has been appreciated that oxidized products of LDL are responsible for plaque formation properties previously attributed to the intact particle. The goal of this article is to review the recent understanding of the LDL oxidation pathway. The role of oxidized products and key enzymes (lipoprotein-associated phospholipase A2 and carboxyl ester lipase) are also extensively discussed in the context of clinical conditions.

Indexed as

atherosclerosiscarboxyl ester lipaselipoprotein-associated phospholipase A2lipoproteins

Identifiers

PMID23515030
PMCPMC3598136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.